The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 04, 2012
Filed:
Apr. 24, 2008
Elena S. Koltun, Foster City, CA (US);
Patrick Kearney, San Francisco, CA (US);
Naing Aay, San Mateo, CA (US);
Arlyn Arcalas, South San Francisco, CA (US);
Wai Ki Vicky Chan, San Francisco, CA (US);
Jeffry Kimo Curtis, San Anselmo, CA (US);
Hongwang Du, Millbrae, CA (US);
Ping Huang, Mountain View, CA (US);
Brian Kane, Lynchburg, VA (US);
Moon Hwan Kim, Palo Alto, CA (US);
Michael Pack, San Francisco, CA (US);
Amy L. Tsuhako, Milpitas, CA (US);
Wei Xu, Danville, CA (US);
Cristiana A. Zaharia, Redwood City, CA (US);
Peiwen Zhou, Palo Alto, CA (US);
Elena S. Koltun, Foster City, CA (US);
Patrick Kearney, San Francisco, CA (US);
Naing Aay, San Mateo, CA (US);
Arlyn Arcalas, South San Francisco, CA (US);
Wai Ki Vicky Chan, San Francisco, CA (US);
Jeffry Kimo Curtis, San Anselmo, CA (US);
Hongwang Du, Millbrae, CA (US);
Ping Huang, Mountain View, CA (US);
Brian Kane, Lynchburg, VA (US);
Moon Hwan Kim, Palo Alto, CA (US);
Michael Pack, San Francisco, CA (US);
Amy L. Tsuhako, Milpitas, CA (US);
Wei Xu, Danville, CA (US);
Cristiana A. Zaharia, Redwood City, CA (US);
Peiwen Zhou, Palo Alto, CA (US);
Exelixis, Inc., South San Francisco, CA (US);
Abstract
A compound having Formula I: or a pharmaceutically acceptable salt thereof, wherein X, R, R and R are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof. The compounds of Formula I are inhibitors of Casein kinase II (CK2) pathways.